Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

63270

registered interest
date	23/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	GP Surgeries: Repairs and Maintenance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many general practitioner practices were (a) refurbished and (b) replaced in each of the last 10 years.
tabling member constituency	Copeland
tabling member printed	Mr Jamie Reed
uin	201710
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>Prior to April 2013, granting funding for the refurbishment and replacement of general practitioner premises was the responsibility of primary care trusts (PCTs). Information pertaining to this period is not held centrally and could only be obtained at disproportionate cost.</p><p> </p><p>Responsibility for funding general practice premises development has now been transferred to NHS England.</p><p> </p><p>Between 1 April 2013 and 1 April 2014, more than 100 business cases for premises development were approved by NHS England. NHS England <ins class="ministerial">will be publishing </ins><del class="ministerial">has now published</del> Principles of Good Practice <ins class="ministerial">later in the autumn. This </ins> <del class="ministerial">that</del> set<ins class="ministerial">s</ins> out how <del class="ministerial">area</del> teams should review and prioritise business case proposals, and since 1 April 2014 a further 46 business cases have been approved.</p><p> </p><p> </p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 26/06/2014 14:49:17 question first ministerially corrected 11/09/2014 13:48:27 answering member 1439 label Biography information for Norman Lamb previous answer version 6377 answering member constituency North Norfolk answering member printed Norman Lamb answering member 1439 label Biography information for Norman Lamb
tabling member	1503 label Biography information for Mr Jamie Reed

63274

registered interest
date	23/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what funding his Department allocated for the treatment of pancreatic cancer in each of the last five years.
tabling member constituency	Belfast South
tabling member printed	Dr Alasdair McDonnell
uin	201702
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>Data is not available at the level of detail being requested. However, information is shown in the following table on the spend on upper gastrointestinal and ‘other' cancers for the period stated.</p><p> </p><p>Estimated expenditure on upper gastrointestinal cancers and ‘other' cancers, 2008-09 to 2012-13, £ billions in 2012-13 prices</p><p> </p><table><tbody><tr><td> </td><td><p>2008-09</p></td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td></tr><tr><td><p>Cancers and Tumours - Upper Gastrointestinal</p></td><td><p>0.24</p></td><td><p>0.28</p></td><td><p>0.20</p></td><td><p>0.20</p></td><td><p>1.55</p></td></tr><tr><td><p>Cancers and Tumours - Other</p></td><td><p>2.21</p></td><td><p>2.57</p></td><td><p>2.95</p></td><td><p>3.00</p></td><td><p>0.63</p></td></tr></tbody></table><p><strong> </strong></p><p><em>Source</em>:</p><p>Programme budgeting data, NHS England</p><p><strong> </strong></p><p>It should be noted that the data are not a reliable source for making year on year comparisons due to changes to the data collection methodology.</p><p> </p><p>Further, not all expenditure can be allocated to a disease based category – therefore some expenditure will be allocated as ‘miscellaneous'. General practitioner expenditure is also not included within the estimates.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 26/06/2014 14:59:07 answering member 3918 label Biography information for Jane Ellison
tabling member	1596 label Biography information for Dr Alasdair McDonnell

63275

registered interest
date	23/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what funding his Department has allocated for research into pancreatic cancer in the most recent period for which figures are available.
tabling member constituency	Belfast South
tabling member printed	Dr Alasdair McDonnell
uin	201703
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>The Department is fully committed to clinical and applied research into cancer prevention, diagnosis and treatment. The Department's National Institute for Health Research (NIHR) welcomes funding applications for research into any aspect of human health, including pancreatic cancer. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and the National Health Service, value for money and scientific quality.</p><p> </p><p>The National Cancer Research Institute (NCRI) is a United Kingdom-wide partnership between the Government, charity and industry which promotes co-operation in cancer research among the 22 member organisations. An analysis of spend data submitted by NCRI partners covering the period from 2002 to 2011 is available on the NCRI website at:</p><p> </p><p>www.ncri.org.uk/wp-content/uploads/2013/11/2013-NCRI-Cancer-research-spend-in-the-UK-2002-2011_data-package.xlsx</p><p> </p><p>This analysis includes data for all cancer research, for site-specific research and for individual sites including pancreatic cancer. Between 2002 and 2011, the proportion of site-specific funding spent on pancreatic cancer research almost doubled.</p><p> </p><p>In August 2011, the Government announced £800 million investment over five years in a series of NIHR Biomedical Research Centres and Units, including £61.5 million funding for the Royal Marsden/Institute of Cancer Research Biomedical Research Centre, and £6.5 million funding for the Liverpool Biomedical Research Unit in gastrointestinal disease (which has a major focus on pancreatic cancer). Some research they conduct is relevant to multiple cancer sites.</p><p> </p><p>The UK Clinical Research Network Portfolio Database currently has 15 studies in pancreatic cancer listed.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 26/06/2014 14:46:46 answering member 1439 label Biography information for Norman Lamb
tabling member	1596 label Biography information for Dr Alasdair McDonnell

63280

registered interest
date	23/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the quality of the implementation of National Institute for Health and Care Excellence guidelines on management of metastatic malignant disease of unknown primary.
tabling member constituency	Sefton Central
tabling member printed	Bill Esterson
uin	201750
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>NHS England would expect that service provision for patients with cancer of unknown primary (CUP) takes into account National Institute for Health and Care Excellence guidelines.</p><p> </p><p>Services for people with cancer are subject to assessment and assurance through the National Cancer Peer Review Programme. Assessment of compliance is made against Commissioning for Quality and Innovation measures.</p><p> </p><p>The Department does not collect information centrally on the proportion of hospitals in England which have implemented a multidisciplinary team for CUP.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 201748 201752 question first answered 26/06/2014 14:51:51 answering member 3918 label Biography information for Jane Ellison
tabling member	4061 label Biography information for Bill Esterson

63281

registered interest
date	23/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what proportion of hospitals in England have implemented a multidisciplinary team for cancer of unknown primary (CUP) as stated in the National Institute for Health and Care Excellence guideline on CUP.
tabling member constituency	Sefton Central
tabling member printed	Bill Esterson
uin	201748
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>NHS England would expect that service provision for patients with cancer of unknown primary (CUP) takes into account National Institute for Health and Care Excellence guidelines.</p><p> </p><p>Services for people with cancer are subject to assessment and assurance through the National Cancer Peer Review Programme. Assessment of compliance is made against Commissioning for Quality and Innovation measures.</p><p> </p><p>The Department does not collect information centrally on the proportion of hospitals in England which have implemented a multidisciplinary team for CUP.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 201750 201752 question first answered 26/06/2014 14:51:51 answering member 3918 label Biography information for Jane Ellison
tabling member	4061 label Biography information for Bill Esterson

63283

registered interest
date	23/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the minimum level of service provision in hospitals is for patients who have cancer of unknown primary.
tabling member constituency	Sefton Central
tabling member printed	Bill Esterson
uin	201752
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>NHS England would expect that service provision for patients with cancer of unknown primary (CUP) takes into account National Institute for Health and Care Excellence guidelines.</p><p> </p><p>Services for people with cancer are subject to assessment and assurance through the National Cancer Peer Review Programme. Assessment of compliance is made against Commissioning for Quality and Innovation measures.</p><p> </p><p>The Department does not collect information centrally on the proportion of hospitals in England which have implemented a multidisciplinary team for CUP.</p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 201748 201750 question first answered 26/06/2014 14:51:51 answering member 3918 label Biography information for Jane Ellison
tabling member	4061 label Biography information for Bill Esterson

63284

registered interest
date	23/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Genito-urinary Medicine: Scotland
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the decision of the Scottish government to suspend the use of transvaginal mesh for pelvic organ prolapse and stress urinary incontinence.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	201884
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>The Department, NHS England and the Medicines and Healthcare products Regulatory Agency have been working with the clinical community to address the concerns that have been raised about transvaginal mesh implants. A working group, which includes patient representatives and is chaired by NHS England, has been set up to identify ways to tackle them. The Department is not currently aware of any new evidence which would support a suspension of procedures involving vaginal mesh in advance of that group's work being taken forward.</p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 26/06/2014 14:36:49 answering member 1439 label Biography information for Norman Lamb
tabling member	4036 label Biography information for Luciana Berger

63285

registered interest
date	23/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chlamydia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many chlamydia tests were supplied by (a) pharmacies, (b) GPs, (c) sexual health clinics and (d) an online service in 2012-13.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	201883
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>The number of chlamydia tests by testing service type and upper tier local authority, 15-24 year olds, in England for the most recent year for which data are available (2013) has been placed in the Library.</p><p> </p><p>The number of chlamydia tests by testing service type and upper tier local authority, 15-24 year olds, in England for 2012 has been placed in the Library.</p><p> </p><p>Tests done through online services cannot be specifically identified in the dataset and are reported to the Chlamydia Testing Activity Dataset as “other”.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 26/06/2014 14:47:08 answering member 3918 label Biography information for Jane Ellison attachment 1 file name PQ201883 - Lib Doc - Table.doc title Library Document
tabling member	4036 label Biography information for Luciana Berger

63286

registered interest
date	23/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chlamydia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to encourage re-testing of all young adults who test positive for chlamydia; and how many young adults are being re-tested after receiving treatment for chlamydia.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	201881
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>In August 2013, following an evidence review and professional and public consultation, the National Chlamydia Screening Programme (NCSP) updated recommended case management for those testing positive for chlamydia to include the routine offering of re-testing, around three months after treatment. A position statement was published which summarises the consultation process and key feedback received, sets out considerations for local implementation and outlines resources to be developed by the NCSP:</p><p> </p><p>www.chlamydiascreening.nhs.uk/ps/resources/re-testing/NCSP%20Position%20Statement_Re-testing%20of%20Positive%20Chlamydia%20Cases_August%202013_FINAL.pdf</p><p> </p><p>Local authorities are responsible for the commissioning of chlamydia screening and the NCSP provides the following resources to support commissioners to encourage re-testing after a chlamydia diagnosis:</p><p> </p><p>- Discussion guide for healthcare professionals:</p><p>http://www.chlamydiascreening.nhs.uk/ps/resources/re-testing/Chlamydia%20re-testing%20discussion%20guide%20March%202014.pdf</p><p> </p><p>- Models of existing practice:</p><p>http://www.chlamydiascreening.nhs.uk/ps/resources/re-testing/Chlamydia%20re-testing%20guidance%20-%20Models%20of%20Practice%20March%202014.pdf</p><p> </p><p>A local audit tool is also in development.</p><p><strong> </strong></p><p>Public Health England monitors re-testing rates at seven to 14 weeks following a diagnosis using data from the genitourinary medicine clinic activity dataset (GUMCAD) and the chlamydia testing activity dataset. Rates of re-testing following a chlamydia diagnosis are calculated quarterly. The most recently available data are for diagnoses made between July and September 2013. Re-testing rates are reported separately for GUM and tests in other settings, as individuals cannot be identified between systems due to the anonymous nature of GUM clinic attendances.</p><p> </p><p>Re-testing rate at seven to 14 weeks after a diagnosis, among 15-24 year olds, for those diagnosed between July and September 2013:</p><p> </p><p>- GUM clinics: 11.8%</p><p>- Other settings: 13.1%</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 26/06/2014 14:33:36 answering member 3918 label Biography information for Jane Ellison
tabling member	4036 label Biography information for Luciana Berger

63287

registered interest
date	23/06/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chlamydia
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many 16 to 25 year olds in each local authority area (a) were tested for chlamydia and (b) tested positive for chlamydia in 2012-13.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	201882
answer	answer is ministerial correction date of answer 26/06/2014 answer text <p>The information is not available in the requested format.</p><p> </p><p>The number of chlamydia tests and diagnosis in each upper tier local authority in England, 15 to 24 year olds, for the most recent year for which data are available (2013) has been placed in the Library.</p><p> </p><p>The number of chlamydia tests and diagnosis in each upper tier local authority in England, 15 to 24 year olds for 2012 has been placed in the Library.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 26/06/2014 14:49:08 answering member 3918 label Biography information for Jane Ellison attachment 1 file name PQ201882 - Lib Doc - Table.doc title Library Document
tabling member	4036 label Biography information for Luciana Berger